Aranesp is used to treat anemia caused by chronic kidney failure or chemotherapy. It stimulates bone marrow and increases red blood cell production, which helps raise hemoglobin levels and improve tissue oxygen supply. This, in turn, reduces persistent fatigue, enhances the patient's physical and mental capacity, and makes them more capable of performing daily activities normally.
Aranesp is also an important treatment that reduces the need for repeated blood transfusions and helps control complications of anemia, such as poor concentration, shortness of breath, and dizziness. Adherence to the doses prescribed by the doctor can lead to a significant improvement in health and increase the patient's level of activity and vitality, making it an essential part of treatment plans for chronic anemia associated with kidney disease or chemotherapy.